Literature DB >> 11160298

A critical role for CD2 in both thymic selection events and mature T cell function.

T Sasada1, E L Reinherz.   

Abstract

To examine the function of CD2 in vivo, N15 TCR transgenic (tg) RAG-2(-/-) H-2(b) mice bearing a single TCR specific for the vesicular stomatitis virus octapeptide bound to the H-2K(b) molecule were compared on a wild-type or CD2(-/-) background. In N15tg RAG-2(-/-) CD2(-/-) mice, thymic dysfunction is evident by 6 wk with a pre-TCR block in the CD4(-)CD8(-) double-negative thymocytes at the CD25(+)CD44(-) stage. Moreover, mature N15tg RAG-2(-/-) CD2(-/-) T cells are approximately 100-fold less responsive to vesicular stomatitis virus octapeptide and unresponsive to weak peptide agonists, as judged by IFN-gamma production. Repertoire analysis shows substantial differences in Valpha usage between non-tg C57BL/6 (B6) and B6 CD2(-/-) mice. Collectively, these findings show that CD2 plays a role in pre-TCR function in double-negative thymocytes, TCR selection events during thymocyte development, and TCR-stimulated cytokine production in mature T cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11160298     DOI: 10.4049/jimmunol.166.4.2394

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  CD2 molecules redistribute to the uropod during T cell scanning: implications for cellular activation and immune surveillance.

Authors:  Elena V Tibaldi; Ravi Salgia; Ellis L Reinherz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

2.  A feline CD2 homologue interacts with human red blood cells.

Authors:  Masayuki Shimojima; Yorihiro Nishimura; Takayuki Miyazawa; Kentaro Kato; Kazuya Nakamura; Yoshihiro Izumiya; Hiroomi Akashi; Yukinobu Tohya
Journal:  Immunology       Date:  2002-03       Impact factor: 7.397

Review 3.  Receptor-directed therapy of T-cell leukemias and lymphomas.

Authors:  John C Morris; Thomas A Waldmann; John E Janik
Journal:  J Immunotoxicol       Date:  2008-04       Impact factor: 3.000

4.  Sonic hedgehog negatively regulates pre-TCR-induced differentiation by a Gli2-dependent mechanism.

Authors:  Nicola J Rowbotham; Ariadne L Hager-Theodorides; Anna L Furmanski; Susan E Ross; Susan V Outram; Johannes T Dessens; Tessa Crompton
Journal:  Blood       Date:  2009-03-09       Impact factor: 22.113

5.  Identification of genomic classifiers that distinguish induction failure in T-lineage acute lymphoblastic leukemia: a report from the Children's Oncology Group.

Authors:  Stuart S Winter; Zeyu Jiang; Hadya M Khawaja; Timothy Griffin; Meenakshi Devidas; Barbara L Asselin; Richard S Larson
Journal:  Blood       Date:  2007-05-10       Impact factor: 22.113

6.  Bovine CD2-/NKp46+ cells are fully functional natural killer cells with a high activation status.

Authors:  Preben Boysen; Ingrid Olsen; Ingvild Berg; Siri Kulberg; Grethe M Johansen; Anne K Storset
Journal:  BMC Immunol       Date:  2006-04-27       Impact factor: 3.615

7.  Common Molecular Alterations in Canine Oligodendroglioma and Human Malignant Gliomas and Potential Novel Therapeutic Targets.

Authors:  Dana Mitchell; Sreenivasulu Chintala; Kaleigh Fetcko; Mario Henriquez; Brij N Tewari; Atique Ahmed; R Timothy Bentley; Mahua Dey
Journal:  Front Oncol       Date:  2019-08-14       Impact factor: 6.244

Review 8.  CD2 Immunobiology.

Authors:  Christian Binder; Filip Cvetkovski; Felix Sellberg; Stefan Berg; Horacio Paternina Visbal; David H Sachs; Erik Berglund; David Berglund
Journal:  Front Immunol       Date:  2020-06-09       Impact factor: 7.561

9.  Development of double-positive thymocytes at single-cell resolution.

Authors:  Young Li; Kun Li; Lianbang Zhu; Bin Li; Dandan Zong; Pengfei Cai; Chen Jiang; Pengcheng Du; Jun Lin; Kun Qu
Journal:  Genome Med       Date:  2021-03-26       Impact factor: 11.117

Review 10.  Promise and challenges of clinical non-invasive T-cell tracking in the era of cancer immunotherapy.

Authors:  Dario Gosmann; Lisa Russelli; Angela M Krackhardt; Calogero D'Alessandria; Wolfgang A Weber; Markus Schwaiger
Journal:  EJNMMI Res       Date:  2022-01-31       Impact factor: 3.138

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.